Compendia Conflict Of Interest White Paper A Precursor To New Regulations
Executive Summary
Compendia publishers can expect to see new regulations regarding transparency and conflict of interest by the end of the year, and those rules could have an effect on whether a compendium will be recognized by CMS as a source for making coverage decisions for off-label drug uses